Drawing for IMCA

USPTO serial 79375787

IMCA

Reviewed by CopyMark Law Group

Reg. 7484102Status 700Registered
Filing date
Status date
Registration date
Aug 27, 2024
Examiner
MESSICK, TABITHA LEE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMCA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

R. Peter Spies

R. Peter Spies DTL, Ltd160 N. Wacker DriveSuite 500Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Arrays of filtering microwells for the analysis of complex bio-molecules for medical use in human or veterinary medicine; biological preparations for medical use for diagnostics of cardiovascular diseases, in oncology, inflammatory, autoimmune and infectious diseases; chemical preparations for medical use for diagnostics of cardiovascular diseases, in oncology, inflammatory, autoimmune and infectious diseases; pharmaceutical preparations for analysis, diagnosis and prognosis, namely, treatment of cardiovascular diseases, in oncology or inflammatory diseases; chemical reagents for medical and pharmacological use; diagnostic biomarker reagents for medical use and conducting pharmacology studiesACTIVE—
010Medical apparatus for analysis, diagnosis and prognosis for medical use for treatment of cardiovascular diseases, for use in oncology, for use infectiology or inflammatory diseases in human or veterinary medicine; medical apparatus for analysis, diagnosis and prognosis, namely, treatment of cardiovascular diseases; analysis, diagnosis and prognosis devices for medical use and medical research; medical devices for analysis, diagnosis and prognosis of cardiovascular diseases; medical devices, namely, analytical devices for medical use in biomarker identification; portable analysis devices for in vitro diagnosis for medical use or medical research or medicine production; clinical chemistry analyzers of complex bio-molecules and autoimmune and inflammatory-related biomarkers for medical use; medical device in the nature of analysis device for medical use based on miniaturized immunological technology for treatment of cardiovascular diseases, infectious diseases, oncology, autoimmune diseases or inflammatory diseases.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 8, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 14, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 14, 2025FIMPFINAL DISPOSITION PROCESSED—
Jan 17, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 2, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 1, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 28, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 27, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 27, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 11, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 4, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 4, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 4, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 4, 2024XAECEXAMINER'S AMENDMENT ENTERED—
May 4, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 4, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
May 4, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 4, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 4, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 4, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 4, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 9, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 8, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2024DOCKASSIGNED TO EXAMINER—
Aug 15, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance